Do you want to read an article? Please log in or register.
Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles
Rheumatoid Arthritis
Related content
Rheumatoid Arthritis
Epstein-Barr virus and rheumatoid arthritis
Joint Bone Spine.
Balandraud N, Roudier J
doi: 10.1016/j.jbspin.2017.04.011.
Molecular diversity of IgG responses to Epstein-Barr virus proteins in asymptomatic Epstein-Barr virus carriers
J Gen Virol.
Goswami R, Shair KHY, Gershburg E
doi: 10.1099/jgv.0.000891.
Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawal
J Neuroimmunol.
Serafini B, Scorsi E, Rosicarelli B, Rigau V, Thouvenot E, Aloisi F
doi: 10.1016/
Rheumatoid Arthritis
Weight Change During the Early Rheumatoid Arthritis Period and Risk of Subsequent Mortality in Women With Rheumatoid Arthritis and Matched Comparators
Arthritis Rheumatol.
Sparks JA, Chang SC, Nguyen US, Barbhaiya M, Tedeschi SK, Lu B, Kreps DJ, Costenbader KH, Zhang Y, Choi HK, Karlson EW
doi: 10.1002/art.40346.
Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins
J Neuroimmunol.
Lindsey JW
doi: 10.1016/j.jneuroim.
Autoimmune DiseaseSystemic Lupus Erythematosus
Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals
Ann Rheum Dis.
Jog NR, Young KA, Munroe ME, Harmon MT, Guthridge JM, Kelly JA, Kamen DL, Gilkeson GS, Weisman MH, Karp DR, Gaffney PM, Harley JB, Wallace DJ, Norris JM, James JA
doi: 10.1136/annrheumdis-
COMMENTED
Rheumatoid Arthritis
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort
★ 2
Recommended and commented by
Dr Heino Prillwitz, Faculty Member
Arthritis Res Ther.
Lukas C, Mary J, Debandt M, Daïen C, Morel J, Cantagrel A, Fautrel B, Combe B
doi: 10.1186/s13075-019-2020-x.
Rheumatoid Arthritis
Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Active Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Results of a Randomized, Double-blind, Placebo-controlled Phase 2 study
Arthritis Rheumatol
Tanaka Y, Takeuchi T, Yamanaka H, Nanki T, Umehara H, Yasuda N, Tago F, Kitahara Y, Kawakubo M, Torii K, Hojo S, Kawano T, Imai T
doi: 10.1002/art.41555
Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
Front Oncol.
El-Sharkawy A, Al Zaidan L, Malki A
doi: 10.3389/fonc.2018.00265.